Biogen Inc. - Company & Market Research Reports

Home /
Companies /
Biogen Inc.

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

REFINE BY

KEYWORD

CATEGORIES

Central Nervous System Drugs 147
Immune Disorders Drugs 79
Genomics 78
Biopharmaceuticals 77
Drug Discovery 66
Oncology Drugs 51
Biotechnology 49
Pharmaceuticals 43
Musculoskeletal Disorders Drugs 41
Hematological Drugs 39
Biosimilars and Biosuperiors 30
Alzheimer's Disease Drugs 27
Cardiovascular Drugs 26
Clinical Trials 26
Allergy and Immunology 20
Infusions and Injectables 20
Optical Disorders Drugs 19
Respiratory Drugs 18
Mental Disorders Drugs 18
Infectious Diseases Drugs 17
Gastrointestinal Drugs 17
Needles and Syringes 16
E-Healthcare 14
Psoriasis Drugs 14
Pharmaceutical Manufacturing 14
Immunosuppressive Drugs 14
Neurology 13
Healthcare Services 13
Drug Delivery 12
Hematology 12
Endocrine and Metabolic Disorders Drugs 12
Lymphoma Drugs 11
Analgesics 10
Leukemia Drugs 9
Optical 9
Diagnostics 9
Liver and Kidney Disorders Drugs 9
Therapeutic Area 7
Drugs by Therapeutic Area 7
Pulmonary Medicine 7
Company Reports 6
Enzymes 6
Medical Devices 6
Hospital Management 5
Cardiology 5
Oncology 5
Schizophrenia Drugs 5
Proteomics 4
Neurology Devices 4
Vaccines 4
Dermatological Drugs 4
Pharmaceutical Intermediates 3
Generic Drugs 3
Pharmacoeconomics 3
Lung Cancer Drugs 3
Stem Cells 3
Biomaterials 3
Dermatology 3
Mental Health 3
Vitamins and Dietary Supplements 3
Laboratory Equipment 3
Gastroenterology 3
In Vitro Diagnostics 2
Managed Care 2
Diabetes Devices 2
Skin Cancer Drugs 2
Nanomedicine 2
Anxiety Drugs 2
Asthma Drugs 2
Urology and Nephrology 1
Diabetes Drugs 1
Women's Health 1
Fertility Services 1
Breast Cancer Drugs 1
Prostate Cancer Drugs 1
Colon Cancer Drugs 1
Cervical Cancer Drugs 1
Medical Imaging 1
Orthopedic Devices 1
Infectious Disease Testing 1
Computed Tomography 1
Transdermal and Transmucosal Drug Delivery 1
Biomarkers 1
Surgical Procedures 1
Contrast Media 1
Kidney Cancer Drugs 1
Antibiotics 1
Clinical Skills 1
Pediatrics 1
Anatomy 1
Allergy Drugs 1
Sexual and Reproductive Health Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



272 reviews

908 Results (Page 12 of 46)
- Relevance
  Sort by

Insulin Pens - Market Insights, Competitive Landscape, and Market Forecast - 2030

 Drug Pipelines
July 2024
100 Pages
Global

From

€3422EUR$3,750USD£2,908GBP

Global Biosimilars Business and Investment Opportunities - Analysis & Market Size by Technology, Clinical Trials, Patents, Financial Deals, Competitive Landscape - Q2 2023 Update

 Report
August 2023
1300 Pages
Global

From

€8121EUR$8,900USD£6,901GBP

Synthetic Biology: Global Markets

 Report
August 2024
137 Pages
Global

From

€4243EUR$4,650USD£3,605GBP

Global Orphan Cancer Drug Market, Drug Sales, Price & Clinical Trials Insight 2028

 Report
July 2022
2190 Pages
Global

From

€3285EUR$3,600USD£2,791GBP

Neurodegenerative Disease - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
120 Pages
Global

From

€4334EUR$4,750USD£3,683GBP

NEED HELP FINDING THE RIGHT PRODUCT? Eman will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Cancer Monoclonal Antibodies Market Report 2025

 Report
March 2025
250 Pages
Global

From

€4097EUR$4,490USD£3,481GBP

Monoclonal Antibodies Market Size, Share & Trends Analysis Report by Source Type (Chimeric, Murine, Humanized, Human), by Production Type (In Vivo, In Vitro), by Application, by End-use, by Region, and Segment Forecasts, 2022-2030

 Report
August 2022
120 Pages
Global

From

€5429EUR$5,950USD£4,613GBP

Autoimmune and Inflammatory Immunomodulators Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
August 2024
102 Pages
Global

From

€3500EUR$4,109USD£3,078GBP

Integrin Alpha4beta1 Antagonists - Pipeline Insight, 2025

 Drug Pipelines
April 2025
60 Pages
Global

From

€1369EUR$1,500USD£1,163GBP

Crohn's Disease (Regional Enteritis) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
April 2022
632 Pages
Global

From

€2281EUR$2,500USD£1,938GBP

Psoriasis Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
January 2024
93 Pages
Global

From

€3500EUR$4,109USD£3,078GBP

Neuropathic Pain Market Report 2025

 Report
March 2025
200 Pages
Global

From

€4097EUR$4,490USD£3,481GBP

Retinal Biologics Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4097EUR$4,490USD£3,481GBP

Brutons Tyrosine Kinase (BTK) Inhibitors - Pipeline Insight, 2025

 Clinical Trials
April 2025
100 Pages
Global

From

€1825EUR$2,000USD£1,551GBP

Multiple Sclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
November 2022
696 Pages
Global

From

€2281EUR$2,500USD£1,938GBP

Optic Neuritis- Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1141EUR$1,250USD£969GBP

Electronic Trial Master File (ETMF) - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
117 Pages
Global

From

€4334EUR$4,750USD£3,683GBP

Systemic Lupus Erythematosus - Pipeline Review, H2 2020

 Drug Pipelines
November 2020
816 Pages
Global

From

€2281EUR$2,500USD£1,938GBP

Rare Diseases Market Report 2024-2034

 Report
May 2024
344 Pages
Global

From

€5299EUR$6,010USD£4,350GBP

Central Nervous System Therapeutics Market Report by Disease, Application, and Region 2025-2033

 Report
April 2025
136 Pages
Global

From

€2737EUR$2,999USD£2,325GBP

908 Results (Page 12 of 46)
- 1
- 10
- 11
- 12
- 13
- 14

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.